• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MDS
Click for more information
6.25% 15.0¢

MIDAS RESOURCES LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
MDSFortitude Resource UpdatePRICE SENSITIVE06/05/10
MDSQuarterly Cashflow ReportPRICE SENSITIVE29/04/10
MDSDrilling Completed at West Pilbara Iron Ore ProjectPRICE SENSITIVE29/04/10
MDSQuarterly Activities ReportPRICE SENSITIVE28/04/10
MDSDrilling Commences at West PilbaraPRICE SENSITIVE20/04/10
MDSMidas to Drill West Pilbara Iron Ore Target Next WeekPRICE SENSITIVE09/04/10
MDSMidas Expands Pilbara Iron Ore Plans With New TenementPRICE SENSITIVE03/03/10
MDSKEY IRON ORE TENEMENT GRANTEDPRICE SENSITIVE24/02/10
MDSResults of Fortitude South RC DrillingPRICE SENSITIVE15/02/10
MDSRC Drilling Commences at Foritude SouthPRICE SENSITIVE28/01/10
MDSQuarterly Cashflow ReportPRICE SENSITIVE27/01/10
MDSMidas Quarterly Activities ReportPRICE SENSITIVE27/01/10
GIR +Agreement on Nifty area applicationsPRICE SENSITIVE16/11/09
MDSResults from Yandicoogina TenementsPRICE SENSITIVE30/10/09
MDSQuarterly Cashflow ReportPRICE SENSITIVE27/10/09
MDSMidas Resources Quarterly Activities ReportPRICE SENSITIVE20/10/09
MDSDisclosure DocumentPRICE SENSITIVE16/10/09
MDSFully Underwritten Renounceable Rights IssuePRICE SENSITIVE16/10/09
MDSProgress ReportPRICE SENSITIVE16/09/09
MDSExtension to Sunset Well Option AgreementPRICE SENSITIVE09/09/09
MDSMidas Applies for Tenements In Paterson Range ProvincePRICE SENSITIVE18/08/09
MDSMidas to Complete Acquisition of Pilbara Iron Ore TenementsPRICE SENSITIVE13/08/09
MDSSignificant Results Fron Iron Ore TenementsPRICE SENSITIVE30/07/09
MDSQuarterly Cashflow ReportPRICE SENSITIVE28/07/09
MDSMidas Resources Limited Quarterly Activities ReportPRICE SENSITIVE27/07/09
MDSMidas to Acquire Pilbara Iron Ore TenementsPRICE SENSITIVE29/06/09
MDSTrading HaltPRICE SENSITIVE26/06/09
MDSQuarterly Cashflow ReportPRICE SENSITIVE20/04/09
MDSQuarterly Activities ReportPRICE SENSITIVE20/04/09
MDSMidas Withdraws from JV in Western ChinaPRICE SENSITIVE27/02/09
MDSQuarterly Cashflow ReportPRICE SENSITIVE20/01/09
MDSQuarterly Activities ReportPRICE SENSITIVE16/01/09
AGG +AngloGold Ashanti to undertake Fortitude Mining StudyPRICE SENSITIVE08/01/09
MDSFortitude Resource Update
06/05/10PRICE SENSITIVE
MDSQuarterly Cashflow Report
29/04/10PRICE SENSITIVE
MDSDrilling Completed at West Pilbara Iron Ore Project
29/04/10PRICE SENSITIVE
MDSQuarterly Activities Report
28/04/10PRICE SENSITIVE
MDSDrilling Commences at West Pilbara
20/04/10PRICE SENSITIVE
MDSMidas to Drill West Pilbara Iron Ore Target Next Week
09/04/10PRICE SENSITIVE
MDSMidas Expands Pilbara Iron Ore Plans With New Tenement
03/03/10PRICE SENSITIVE
MDSKEY IRON ORE TENEMENT GRANTED
24/02/10PRICE SENSITIVE
MDSResults of Fortitude South RC Drilling
15/02/10PRICE SENSITIVE
MDSRC Drilling Commences at Foritude South
28/01/10PRICE SENSITIVE
MDSQuarterly Cashflow Report
27/01/10PRICE SENSITIVE
MDSMidas Quarterly Activities Report
27/01/10PRICE SENSITIVE
GIR +Agreement on Nifty area applications
16/11/09PRICE SENSITIVE
MDSResults from Yandicoogina Tenements
30/10/09PRICE SENSITIVE
MDSQuarterly Cashflow Report
27/10/09PRICE SENSITIVE
MDSMidas Resources Quarterly Activities Report
20/10/09PRICE SENSITIVE
MDSDisclosure Document
16/10/09PRICE SENSITIVE
MDSFully Underwritten Renounceable Rights Issue
16/10/09PRICE SENSITIVE
MDSProgress Report
16/09/09PRICE SENSITIVE
MDSExtension to Sunset Well Option Agreement
09/09/09PRICE SENSITIVE
MDSMidas Applies for Tenements In Paterson Range Province
18/08/09PRICE SENSITIVE
MDSMidas to Complete Acquisition of Pilbara Iron Ore Tenements
13/08/09PRICE SENSITIVE
MDSSignificant Results Fron Iron Ore Tenements
30/07/09PRICE SENSITIVE
MDSQuarterly Cashflow Report
28/07/09PRICE SENSITIVE
MDSMidas Resources Limited Quarterly Activities Report
27/07/09PRICE SENSITIVE
MDSMidas to Acquire Pilbara Iron Ore Tenements
29/06/09PRICE SENSITIVE
MDSTrading Halt
26/06/09PRICE SENSITIVE
MDSQuarterly Cashflow Report
20/04/09PRICE SENSITIVE
MDSQuarterly Activities Report
20/04/09PRICE SENSITIVE
MDSMidas Withdraws from JV in Western China
27/02/09PRICE SENSITIVE
MDSQuarterly Cashflow Report
20/01/09PRICE SENSITIVE
MDSQuarterly Activities Report
16/01/09PRICE SENSITIVE
AGG +AngloGold Ashanti to undertake Fortitude Mining Study
08/01/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.